KRAS and malignant colon neoplasm: On the other hand, as a percentage of all ras-induced tumors, G12D-K-RAS-p21 occurs in about 25 percent of lung adenocarcinomas, 37 percent in colon cancers and 50 percent in pancreatic cancers [39].